Logo

Southeast Cancer Control Consortium, Inc.

Melanoma

Protocol Number Study Title

CTSU E1697
Phase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b No, T3a-bN0, T4a-b No, and T1-4, N1a, 2a (microscopic) Melanoma


SWOG S0826
A Phase II Study of SCH 727965 in Patients with Stage IV Melanoma
  2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241
Phone: (336) 777-3036 Fax: (336) 777-3177 Email: scccinfo@wfubmc.edu
353,408 hits

Valid CSS!